Literature DB >> 11717410

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

M D Gomes1, S H Lecker, R T Jagoe, A Navon, A L Goldberg.   

Abstract

Muscle wasting is a debilitating consequence of fasting, inactivity, cancer, and other systemic diseases that results primarily from accelerated protein degradation by the ubiquitin-proteasome pathway. To identify key factors in this process, we have used cDNA microarrays to compare normal and atrophying muscles and found a unique gene fragment that is induced more than ninefold in muscles of fasted mice. We cloned this gene, which is expressed specifically in striated muscles. Because this mRNA also markedly increases in muscles atrophying because of diabetes, cancer, and renal failure, we named it atrogin-1. It contains a functional F-box domain that binds to Skp1 and thereby to Roc1 and Cul1, the other components of SCF-type Ub-protein ligases (E3s), as well as a nuclear localization sequence and PDZ-binding domain. On fasting, atrogin-1 mRNA levels increase specifically in skeletal muscle and before atrophy occurs. Atrogin-1 is one of the few examples of an F-box protein or Ub-protein ligase (E3) expressed in a tissue-specific manner and appears to be a critical component in the enhanced proteolysis leading to muscle atrophy in diverse diseases.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11717410      PMCID: PMC64700          DOI: 10.1073/pnas.251541198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Regulation of proteolysis.

Authors:  D Attaix; L Combaret; M N Pouch; D Taillandier
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2001-01       Impact factor: 4.294

2.  The gene expression of ubiquitin ligase E3alpha is upregulated in skeletal muscle during sepsis in rats-potential role of glucocorticoids.

Authors:  D Fischer; X Sun; G Gang; T Pritts; P O Hasselgren
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

Review 3.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

4.  Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.

Authors:  N E Tawa; R Odessey; A L Goldberg
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone.

Authors:  D Chrysis; L E Underwood
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

6.  Identification of a family of human F-box proteins.

Authors:  C Cenciarelli; D S Chiaur; D Guardavaccaro; W Parks; M Vidal; M Pagano
Journal:  Curr Biol       Date:  1999-10-21       Impact factor: 10.834

Review 7.  Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

8.  Functional annotation of a full-length mouse cDNA collection.

Authors:  J Kawai; A Shinagawa; K Shibata; M Yoshino; M Itoh; Y Ishii; T Arakawa; A Hara; Y Fukunishi; H Konno; J Adachi; S Fukuda; K Aizawa; M Izawa; K Nishi; H Kiyosawa; S Kondo; I Yamanaka; T Saito; Y Okazaki; T Gojobori; H Bono; T Kasukawa; R Saito; K Kadota; H Matsuda; M Ashburner; S Batalov; T Casavant; W Fleischmann; T Gaasterland; C Gissi; B King; H Kochiwa; P Kuehl; S Lewis; Y Matsuo; I Nikaido; G Pesole; J Quackenbush; L M Schriml; F Staubli; R Suzuki; M Tomita; L Wagner; T Washio; K Sakai; T Okido; M Furuno; H Aono; R Baldarelli; G Barsh; J Blake; D Boffelli; N Bojunga; P Carninci; M F de Bonaldo; M J Brownstein; C Bult; C Fletcher; M Fujita; M Gariboldi; S Gustincich; D Hill; M Hofmann; D A Hume; M Kamiya; N H Lee; P Lyons; L Marchionni; J Mashima; J Mazzarelli; P Mombaerts; P Nordone; B Ring; M Ringwald; I Rodriguez; N Sakamoto; H Sasaki; K Sato; C Schönbach; T Seya; Y Shibata; K F Storch; H Suzuki; K Toyo-oka; K H Wang; C Weitz; C Whittaker; L Wilming; A Wynshaw-Boris; K Yoshida; Y Hasegawa; H Kawaji; S Kohtsuki; Y Hayashizaki
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

9.  Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4.

Authors:  M Blondel; J M Galan; Y Chi; C Lafourcade; C Longaretti; R J Deshaies; M Peter
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

Review 10.  The F-box protein family.

Authors:  E T Kipreos; M Pagano
Journal:  Genome Biol       Date:  2000-11-10       Impact factor: 13.583

View more
  584 in total

1.  Slowing muscle atrophy: putting the brakes on protein breakdown.

Authors:  Stewart H Lecker; Alfred L Goldberg
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

2.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

3.  Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury.

Authors:  Edward K Merritt; James M Cross; Marcas M Bamman
Journal:  J Burn Care Res       Date:  2012 Mar-Apr       Impact factor: 1.845

4.  Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.

Authors:  Anthony J Kee; Lydie Combaret; Thomas Tilignac; Bertrand Souweine; Eveline Aurousseau; Michel Dalle; Daniel Taillandier; Didier Attaix
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

5.  Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle.

Authors:  Eric J Stevenson; Paul G Giresi; Alan Koncarevic; Susan C Kandarian
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

6.  Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.

Authors:  Sajedah M Hindi; Vivek Mishra; Shephali Bhatnagar; Marjan M Tajrishi; Yuji Ogura; Zhen Yan; Linda C Burkly; Timothy S Zheng; Ashok Kumar
Journal:  FASEB J       Date:  2013-12-10       Impact factor: 5.191

Review 7.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

8.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

9.  Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

Authors:  Hui-Hua Li; Vishram Kedar; Chunlian Zhang; Holly McDonough; Ranjana Arya; Da-Zhi Wang; Cam Patterson
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.